GLAXO
GLAXOSMITHKLINE PHARMA LT

2605.5 -51.94 (-1.99%)

Stop-loss on the minds of GLAXO investors as it performed worse than the broader market

06 Nov, 20255 min read

GLAXOSMITHKLINE PHARMA LT ranked worse than it's peers on Thursday. It returned -1.99% to close at 2605.5. On a day when the overall market breadth was 35%, it closed higher than 70% of the market. In comparison, the benchmark NIFTY-50 index closed today at -0.0034%.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}